196 related articles for article (PubMed ID: 16200842)
1. Randomized controlled trial evaluating response to metformin versus standard therapy in the treatment of adolescents with polycystic ovary syndrome.
Allen HF; Mazzoni C; Heptulla RA; Murray MA; Miller N; Koenigs L; Reiter EO
J Pediatr Endocrinol Metab; 2005 Aug; 18(8):761-8. PubMed ID: 16200842
[TBL] [Abstract][Full Text] [Related]
2. Randomized clinical trial evaluating metformin versus oral contraceptive pills in the treatment of adolescents with polycystic ovarian syndrome.
Al-Zubeidi H; Klein KO
J Pediatr Endocrinol Metab; 2015 Jul; 28(7-8):853-8. PubMed ID: 25781525
[TBL] [Abstract][Full Text] [Related]
3. Metformin therapy in obese adolescents with polycystic ovary syndrome and impaired glucose tolerance: amelioration of exaggerated adrenal response to adrenocorticotropin with reduction of insulinemia/insulin resistance.
Arslanian SA; Lewy V; Danadian K; Saad R
J Clin Endocrinol Metab; 2002 Apr; 87(4):1555-9. PubMed ID: 11932281
[TBL] [Abstract][Full Text] [Related]
4. Endothelial function and insulin resistance in polycystic ovary syndrome: the effects of medical therapy.
Teede HJ; Meyer C; Hutchison SK; Zoungas S; McGrath BP; Moran LJ
Fertil Steril; 2010 Jan; 93(1):184-91. PubMed ID: 19019358
[TBL] [Abstract][Full Text] [Related]
5. Doppler analysis of ovarian stromal blood flow changes after treatment with metformin versus ethinyl estradiol-cyproterone acetate in women with polycystic ovarian syndrome: A randomized controlled trial.
Sahu A; Tripathy P; Mohanty J; Nagy A
J Gynecol Obstet Hum Reprod; 2019 May; 48(5):335-339. PubMed ID: 30316907
[TBL] [Abstract][Full Text] [Related]
6. Insulin-sensitising drugs versus the combined oral contraceptive pill for hirsutism, acne and risk of diabetes, cardiovascular disease, and endometrial cancer in polycystic ovary syndrome.
Costello M; Shrestha B; Eden J; Sjoblom P; Johnson N
Cochrane Database Syst Rev; 2007 Jan; (1):CD005552. PubMed ID: 17253562
[TBL] [Abstract][Full Text] [Related]
7. Metformin versus ethinyl estradiol-cyproterone acetate in the treatment of nonobese women with polycystic ovary syndrome: a randomized study.
Morin-Papunen L; Vauhkonen I; Koivunen R; Ruokonen A; Martikainen H; Tapanainen JS
J Clin Endocrinol Metab; 2003 Jan; 88(1):148-56. PubMed ID: 12519844
[TBL] [Abstract][Full Text] [Related]
8. Effect of 12-month treatment with metformin and/or oral contraceptives on health-related quality of life in polycystic ovary syndrome.
Altinok ML; Ravn P; Andersen M; Glintborg D
Gynecol Endocrinol; 2018 Oct; 34(10):859-863. PubMed ID: 29658344
[TBL] [Abstract][Full Text] [Related]
9. Metformin improves endothelial function and carotid intima media thickness in patients with PCOS.
Kaya MG; Yildirim S; Calapkorur B; Akpek M; Unluhizarci K; Kelestimur F
Gynecol Endocrinol; 2015 May; 31(5):401-5. PubMed ID: 25791462
[TBL] [Abstract][Full Text] [Related]
10. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
[TBL] [Abstract][Full Text] [Related]
11. Effects of medical therapy on insulin resistance and the cardiovascular system in polycystic ovary syndrome.
Meyer C; McGrath BP; Teede HJ
Diabetes Care; 2007 Mar; 30(3):471-8. PubMed ID: 17327307
[TBL] [Abstract][Full Text] [Related]
12. Metformin or Oral Contraceptives for Adolescents With Polycystic Ovarian Syndrome: A Meta-analysis.
Al Khalifah RA; Florez ID; Dennis B; Thabane L; Bassilious E
Pediatrics; 2016 May; 137(5):. PubMed ID: 27244814
[TBL] [Abstract][Full Text] [Related]
13. Improved efficacy of low-dose spironolactone and metformin combination than either drug alone in the management of women with polycystic ovary syndrome (PCOS): a six-month, open-label randomized study.
Ganie MA; Khurana ML; Nisar S; Shah PA; Shah ZA; Kulshrestha B; Gupta N; Zargar MA; Wani TA; Mudasir S; Mir FA; Taing S
J Clin Endocrinol Metab; 2013 Sep; 98(9):3599-607. PubMed ID: 23846820
[TBL] [Abstract][Full Text] [Related]
14. The effects of treatment with drospirenone/ethinyl oestradiol alone or in combination with metformin on elastic properties of aorta in women with polycystic ovary syndrome.
Kaya MG; Calapkorur B; Karaca Z; Yildirim S; Celik A; Akpek M; Unluhizarci K; Kelestimur F
Clin Endocrinol (Oxf); 2012 Dec; 77(6):885-92. PubMed ID: 22563947
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory-metabolic parameters in obese and nonobese normoandrogenemic polycystic ovary syndrome during metformin and oral contraceptive treatment.
Kilic S; Yilmaz N; Zulfikaroglu E; Erdogan G; Aydin M; Batioglu S
Gynecol Endocrinol; 2011 Sep; 27(9):622-9. PubMed ID: 21105835
[TBL] [Abstract][Full Text] [Related]
16. The effects of metformin on insulin resistance and ovarian steroidogenesis in women with polycystic ovary syndrome.
Unlühizarci K; Keleştimur F; Bayram F; Sahin Y; Tutuş A
Clin Endocrinol (Oxf); 1999 Aug; 51(2):231-6. PubMed ID: 10468995
[TBL] [Abstract][Full Text] [Related]
17. Differential Effects on Haemostatic Markers by Metformin and the Contraceptive Pill: A Randomized Comparative Trial in PCOS.
Burchall GF; Piva TJ; Ranasinha S; Teede HJ
Thromb Haemost; 2017 Nov; 117(11):2053-2062. PubMed ID: 29202210
[No Abstract] [Full Text] [Related]
18. Effect of dose escalation of metformin on clinical features, insulin sensitivity and androgen profile in polycystic ovary syndrome.
Yasmin E; Glanville J; Barth J; Balen AH
Eur J Obstet Gynecol Reprod Biol; 2011 May; 156(1):67-71. PubMed ID: 21277073
[TBL] [Abstract][Full Text] [Related]
19. Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study.
Tang T; Glanville J; Hayden CJ; White D; Barth JH; Balen AH
Hum Reprod; 2006 Jan; 21(1):80-9. PubMed ID: 16199429
[TBL] [Abstract][Full Text] [Related]
20. Endocrine and metabolic effects of metformin versus ethinyl estradiol-cyproterone acetate in obese women with polycystic ovary syndrome: a randomized study.
Morin-Papunen LC; Vauhkonen I; Koivunen RM; Ruokonen A; Martikainen HK; Tapanainen JS
J Clin Endocrinol Metab; 2000 Sep; 85(9):3161-8. PubMed ID: 10999803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
